Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03266770 · ClinicalTrials.gov registry record · NA

The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position

A NA study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT03266770 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03266770, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

Traditional ureteral stents are commonly used in renal and ureteral procedures, and their use is associated with many morbidities which can affect patients' quality of life. However, replacement of the distal portion of the stent with a thin material may reduce bladder irritative symptoms and allow the ureterovesical junction to coapt---thereby, reducing urinary reflux. The hypothesis is that the RELIEF stent will offer the same function of traditional ureteral stents with the added benefits of minimizing urinary reflux and reducing irritative bladder symptoms.

Interventions

  • DEVICE RELIEF Stent

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-06-15
Est. Completion 2022-12-12
Phase NA

What the Registry Record Tells You About NCT03266770

The ClinicalTrials.gov registry entry for NCT03266770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which RELIEF Stent is the first listed.

NCT03266770 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03266770 about?

NCT03266770 is a clinical study titled "The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position". Traditional ureteral stents are commonly used in renal and ureteral procedures, and their use is associated with many morbidities which can affect patients' quality of life. However, replacement of the distal portion of the stent with a thin material may reduce bladder irritative symptoms and allow ...

What is the current status of trial NCT03266770?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-06-15. Estimated completion is 2022-12-12.

What interventions are being tested in trial NCT03266770?

The interventions under investigation include: RELIEF Stent (DEVICE).

Who is sponsoring clinical trial NCT03266770?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.